Inventor · disambiguated record
Sanjay Bhanot
Also filed as: BHANOT SANJAY
62 granted patents·48 pending applications·936 citations·filing 2002–2025
99Inventor score
Files withISIS PHARMACEUTICALS INC36BHANOT SANJAY24IONIS PHARMACEUTICALS INC20MONIA BRETT P5FREIER SUSAN M4
Top patents by PatentIndex Score
110 records- 0199US7468431B2Modulation of eIF4E-BP2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Dec 23, 2008·117 cites·30 claims
- 0298US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0398US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 0498US7732590B2Modulation of diacylglycerol acyltransferase 2 expressionISIS PHARMACEUTICALS INC·Filed 2005·Granted Jun 8, 2010·132 cites·31 claims
- 0597US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 0697US8093222B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2009·Granted Jan 10, 2012·46 cites·68 claims
- 0797US7399853B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 15, 2008·105 cites·26 claims
- 0896US7919472B2Enhanced antisense oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·37 cites·20 claims
- 0996US7229976B2Modulation of forkhead box O1A expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Jun 12, 2007·114 cites·35 claims
- 1095US9567587B2Antisense modulation of GCCR expressionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Feb 14, 2017·30 cites·24 claims
- 1195US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 1295US8084437B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2007·Granted Dec 27, 2011·44 cites·19 claims
- 1393US9994855B2Compositions and methods for modulating growth hormone receptor expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jun 12, 2018·9 cites·43 claims
- 1493US8664190B2Methods for treating hypercholesterolemiaFREIER SUSAN M·Filed 2011·Granted Mar 4, 2014·17 cites·13 claims
- 1593US8586554B2Compounds and methods for modulating expression of PTP1BBHANOT SANJAY·Filed 2007·Granted Nov 19, 2013·13 cites·45 claims
- 1693US8258289B2Modulation of diacylglycerol acyltransferase 2 expressionBHANOT SANJAY·Filed 2010·Granted Sep 4, 2012·20 cites·24 claims
- 1793US2025313843A1Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1891US10858657B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 8, 2020·2 cites·18 claims
- 1990US11312962B2Modulators of diacyglycerol acyltransferase 2 (DGAT2)IONIS PHARMACEUTICALS INC·Filed 2019·Granted Apr 26, 2022·2 cites·7 claims
- 2090US8101585B2Compositions and methods for the modulation of JNK proteinsYU XING-XIAN·Filed 2007·Granted Jan 24, 2012·18 cites·30 claims
- 2189US8158598B2Compositions and their uses directed to PTPR alphaBHANOT SANJAY·Filed 2007·Granted Apr 17, 2012·17 cites·20 claims
- 2288US11530410B2Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·1 cites·12 claims
- 2388US8372967B2Compounds and methods for modulating expression of GCCRISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 12, 2013·5 cites·75 claims
- 2487US10793862B2Compositions and methods for modulating growth hormone receptor expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted Oct 6, 2020·1 cites·56 claims
- 2587US9650636B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted May 16, 2017·5 cites·20 claims
- 2687US7960358B2Antisense modulation of stearoyl-CoA desaturase expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·3 cites·17 claims
- 2786US8673871B2Compounds and methods for modulating expression ApoBBHANOT SANJAY·Filed 2007·Granted Mar 18, 2014·4 cites·19 claims
- 2885US8912160B2Methods for treating hypercholesterolemiaISIS PHARMACEUTICALS INC·Filed 2014·Granted Dec 16, 2014·4 cites·13 claims
- 2985US2023137382A1Methods for treating hypercholesterolemiaIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3084US8017760B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·4 cites·13 claims
- 3183US8541388B2Methods for modulating expression of RBP4MONIA BRETT P·Filed 2009·Granted Sep 24, 2013·6 cites·35 claims
- 3283US8362232B2Compounds and methods for modulating expression of SGLT2ISIS PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·3 cites·46 claims
- 3382US7807649B2Modulation of forkhead box O1A expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Oct 5, 2010·4 cites·33 claims
- 3481US7897583B2Compositions and their uses directed to PTPRUISIS PHARMACEUTICALS INC·Filed 2006·Granted Mar 1, 2011·4 cites·36 claims
- 3580US8486904B2Antisense modulation of fibroblast growth factor receptor 4 expressionBHANOT SANJAY·Filed 2008·Granted Jul 16, 2013·3 cites·25 claims
- 3680US2023118177A1Compositions and methods for modulating growth hormone receptor expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3779US8227593B2Modulation of forkhead box O1A expressionDOBIE KENNETH W·Filed 2010·Granted Jul 24, 2012·3 cites·19 claims
- 3878US8642753B2Modulation of glucagon receptor expressionFREIER SUSAN M·Filed 2012·Granted Feb 4, 2014·2 cites·20 claims
- 3978US2023147811A1Modulators of growth hormone receptorIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4077US8969316B2Compounds and methods for modulating expression of DGAT2ISIS PHARMACEUTICALS INC·Filed 2012·Granted Mar 3, 2015·1 cites·20 claims
- 4177US7919476B2Modulation of glucagon receptor expressionISIS PHARMACEUTICALS INC·Filed 2007·Granted Apr 5, 2011·2 cites·33 claims
- 4275US8541387B2Modulation of SMRT expressionPANDEY SANJAY K·Filed 2009·Granted Sep 24, 2013·4 cites·37 claims
- 4374US11312964B2Compositions and methods for modulating growth hormone receptor expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Apr 26, 2022·0 cites·20 claims
- 4474US2025283090A1Modulators of diacyglycerol acyltransferase 2 (dgat2)IONIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4573US9404114B2Antisense modulation of GCGR expressionIONIS PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·1 cites·24 claims
- 4673US7807652B2Modulation of eIF4E-BP2 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Oct 5, 2010·1 cites·20 claims
- 4772US8969314B2Methods for use in modulating miR-122aESAU CHRISTINE·Filed 2006·Granted Mar 3, 2015·1 cites·37 claims
- 4870US2021108211A1Modulators of growth hormone receptorLONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4969US8455456B2Compositions and their uses directed to diacylglycerol acyltransferase 1YU XING-XIAN·Filed 2011·Granted Jun 4, 2013·1 cites·24 claims
- 5068US2015057329A1Compounds and methods for modulating expression apobISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Showing the top 50 of 110 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sanjay Bhanot files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →